US00791X1000 - AEON (XNYS)

AEON Biopharma, Inc. Class A Common Stock Share

0,58 USD

-3,15 % -0,02 USD 24.12.2024 19:31 - USD - NYSE (XNYS) - Current prices and charts at MoneyPeak

Current Prices from AEON Biopharma, Inc. Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change	Daily Change %
NYSE	AEON	USD	24.12.2024 19:31	0,58 USD	0,60 USD	-3,09 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-7,94 %	8,23 %	-21,50 %	-42,48 %	-89,90 %	-93,68 %

Company Profile for AEON Biopharma, Inc. Class A Common Stock Share

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Company Data for AEON Biopharma, Inc. Class A Common Stock Share

Name AEON Biopharma, Inc. Class A Common Stock

Company AEON Biopharma, Inc.

Symbol AEON

Website http://www.aeonbiopharma.com

Primary Exchange

NYSE

ISIN US00791X1000

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Marc Forth

Market Capitalization 33 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 4040 Macarthur Boulevard, 92614 Newport Beach

IPO Date 2023-07-24

Ticker Symbols

Name	Symbol
NYSE	AEON

More Shares

Investors who AEON Biopharma, Inc. Class A Common Stock hold also have the following shares in their portfolio:

foo Asset

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog